Literature DB >> 32364651

Characterization of liver zonation-like transcriptomic patterns in HLCs derived from hiPSCs in a microfluidic biochip environment.

Mathieu Danoy1, Stéphane Poulain2, Myriam Lereau-Bernier1, Sachi Kato2, Benedikt Scheidecker3, Taketomo Kido4, Atsushi Miyajima4, Yasuyuki Sakai3, Charles Plessy2, Eric Leclerc1.   

Abstract

The liver zonation is an important phenomenon characterized by a gradient of several functions along the liver acinus. However, this gradient remains difficult to reproduce in in-vitro conditions, making the obtention of an in-vitro method to recapitulate the liver zonation a challenging issue. In this study, we evaluated the spatial evolution of the transcriptome profile of human induced pluripotent stem cells (hiPSCs) differentiated toward hepatocytes-like cells (HLCs) phenotype in a microfluidic biochip environment. Cells collected at the inlet of the biochip, where the oxygen concentration is higher, were identified by the expression of genes involved in metabolic pathways related to cellular reorganization and cell proliferation. Cells collected in the middle and at the outlet of the biochips, where oxygen concentrations are lower, were characterized by the upregulation of genes involved in cellular detoxification processes (CYP450), PPAR signaling or arginine biosynthesis. A subset of 16 transcription factors (TFs) was extracted and identified as upstream regulators to HNF1A and PPARA. These TFs are also known as regulators to target genes engaged in the Wnt/βcatenin pathway, in the TGFβ/BMP/SMAD signaling, in the transition between epithelial mesenchymal transition (EMT) and mesenchymal epithelial transition (MET), in the homeostasis of lipids, bile acids and carbohydrates homeostasis, in drug metabolism, in the estrogen processing and in the oxidative stress response. Overall, the analysis allowed to confirm a partial zonation-like pattern in hiPSCs-derived HLCs in the microfluidic biochip environment. These results provide important insights into the reproduction of liver zonation in-vitro for a better understanding of the phenomenon.
© 2020 American Institute of Chemical Engineers.

Entities:  

Keywords:  HLCs; hepatocytes; hiPSCs; liver zonation; microfluidic biochips; nanoCAGE

Year:  2020        PMID: 32364651     DOI: 10.1002/btpr.3013

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  4 in total

Review 1.  A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies.

Authors:  Ana S Serras; Joana S Rodrigues; Madalena Cipriano; Armanda V Rodrigues; Nuno G Oliveira; Joana P Miranda
Journal:  Front Cell Dev Biol       Date:  2021-02-22

Review 2.  Engineering Hydrogels for the Development of Three-Dimensional In Vitro Models.

Authors:  Somnath Maji; Hyungseok Lee
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

3.  Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver's Extracellular Matrix.

Authors:  Taha Messelmani; Anne Le Goff; Zied Souguir; Victoria Maes; Méryl Roudaut; Elodie Vandenhaute; Nathalie Maubon; Cécile Legallais; Eric Leclerc; Rachid Jellali
Journal:  Bioengineering (Basel)       Date:  2022-09-05

Review 4.  Modelling urea cycle disorders using iPSCs.

Authors:  Claire Duff; Julien Baruteau
Journal:  NPJ Regen Med       Date:  2022-09-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.